Brevettabilità dei medicamenti

This procedure concerns the rules governing whether medicinal products can be patented. It aims to clarify the conditions under which new drugs and treatments can receive patent protection, impacting innovation and access to medicines. This affects pharmaceutical companies, researchers, and potentially patients by influencing the development of new therapies and their availability on the market.